Frontiers in Surgery 2021 December 8 [Link] Olivia Lauk, Miriam Patella, Thomas Neuer, Ilhan Inci, Walter Weder, Isabelle Opitz Abstract Background: Extrapleural pneumonectomy (EPP) for malignant pleural mesothelioma (MPM) is highly abandoned due to high morbidity and mortality rates and impaired quality of life (QoL). However, there are still rare indications for this intervention. The…

Read More

Frontiers in Oncology 2021 December 1 [Link] Alberto Testori, Gianluca Perroni, Marco Alloisio, Emanuele Voulaz, Veronica Maria Giudici, Umberto Cariboni, Edoardo Bottoni Abstract Background: Persistent air leak is a common complication occurring from 6% to 23% of cases after extended pleurectomy/decortication for malignant pleural mesothelioma. Treatment options for this complication after major lung resection are…

Read More

Therapeutic Advances In Medical Oncology 2021 December 10 [Link] Valérie Gounant, Solenn Brosseau, Gérard Zalcman Abstract Due to occupational asbestosis exposure, the incidence of malignant pleural mesothelioma (MPM) has continuously increased over the last 30 years, with a plateau anticipated around the year 2030 in Western countries. Molecular MPM carcinogenesis involves alterations of NF2, RASSF1,…

Read More

Annals of Thoracic Surgery 2021 October 4 [Link] Moshe Lapidot, Emanuele Mazzola, Samuel Freyaldenhoven, Luis E De León, Michael T Jaklitsch, Raphael Bueno Abstract Background: Postoperative empyema following pleurectomy decortication (PDC) for malignant pleural mesothelioma (MPM) is a serious complication that necessitates prolonged hospitalization. The aim of this study was to determine the incidence, risk…

Read More

Cancers 2021 September 12 [Link] Michael Ried, Julia Kovács, Till Markowiak, Karolina Müller, Gunnar Huppertz, Michael Koller, Hauke Winter, Laura V Klotz, Rudolf Hatz, Julia Zimmermann, Bernward Passlick, Severin Schmid, Mohamed Hassan, Martin E Eichhorn, Hans-Stefan Hofmann Abstract In the context of quality assurance, the objectives were to describe the surgical treatment and postoperative morbidity…

Read More

Cancers 2021 September 12 [Link] Michael Ried, Julia Kovács, Till Markowiak, Karolina Müller, Gunnar Huppertz, Michael Koller, Hauke Winter, Laura V Klotz, Rudolf Hatz, Julia Zimmermann, Bernward Passlick, Severin Schmid, Mohamed Hassan, Martin E Eichhorn, Hans-Stefan Hofmann Abstract In the context of quality assurance, the objectives were to describe the surgical treatment and postoperative morbidity…

Read More

World Journal of Clinical Oncology 2021 August 24 [Link] Javier Luna, Andrea Bobo, Joaquín José Cabrera-Rodriguez, María Pagola, Margarita Martín-Martín, María Ángeles González Ruiz, Miguel Montijano, Aurora Rodríguez, Lira Pelari-Mici, Almudena Corbacho, Marta Moreno, Felipe Couñago Abstract Malignant pleural mesothelioma (MPM) is a rare tumor with poor prognosis and rising incidence. Palliative care is common…

Read More

World Journal of Clinical Oncology 2021 August 24 [Link] Javier Luna, Andrea Bobo, Joaquín José Cabrera-Rodriguez, María Pagola, Margarita Martín-Martín, María Ángeles González Ruiz, Miguel Montijano, Aurora Rodríguez, Lira Pelari-Mici, Almudena Corbacho, Marta Moreno, Felipe Couñago Abstract Malignant pleural mesothelioma (MPM) is a rare tumor with poor prognosis and rising incidence. Palliative care is common…

Read More

Disability and Rehabilitation 2021 August 29 [Link] Simon Ho, Melissa Culligan, Joseph Friedberg, Olga Goloubeva, Victoria Marchese Abstract Purpose: The purpose of this study was to examine the impact of physical function performance and pulmonary function on patient outcomes after lung-sparing surgery for malignant pleural mesothelioma (MPM). Materials and methods: A retrospective review of 54…

Read More

Clinical Oncology 2021 August 12 [Link] T Müdder, G R Sarria, C Henkenberens, J Holz, S Garbe, F Röhner, S Stumpf, T Buchstab, F A Giordano, C Leitzen Abstract Aims: To carry out a dosimetric comparison and constraints feasibility proof of adjuvant radiotherapy through helical tomotherapy or volumetric modulated arc therapy (VMAT) for malignant pleural…

Read More